Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8957762 | Critical Reviews in Oncology/Hematology | 2018 | 27 Pages |
Abstract
In the general population, Performace Status (PS) has traditionally been used to estimate tolerance to chemotherapy, but in the elderly population it is not useful. In this review we summarize the current knowledge about the pharmacology of antineoplastic drugs in the elderly and the tools available to help us identify risk of chemotherapy toxicity in these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Jaime Feliu, Victoria Heredia-Soto, Regina Gironés, Beatriz Jiménez-Munarriz, Juana Saldaña, Carmen Guillén-Ponce, M.J. Molina-Garrido,